A very valid point.
I think the best way to approach this answer is by understanding why cancer cells don't follow the same instructions. In other words, what causes cancer cells that arise from liver tissue to grow continuously forming a tumor, while healthy liver cells "know" when to die and regenerate new cells. In fact, liver mass is proportional to one's body size - bigger people have bigger livers than smaller people.
To study liver size, a study was conducted on mice where it was found that bile acids regulate liver regeneration, and might also help determine liver size. Bile acid synthesis is regulated by cytochrome P450, polypeptide 1 (
CYP7A1) - this endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway in the liver, which converts cholesterol to bile acids. The expression of
CYP7A1 is down-regulated by of
FGF19 (in mice,
FGF15), produced in the intestine.
When livers of FRGN mice can be destroyed and then fully repopulated with human hepatocytes, the humanized livers grow to a larger size than the original mouse liver. The humanized livers also express higher levels of
CYP7A1. This is because the human liver cells do not recognize the mouse FGF15 - they only respond to the human form,
FGF19. The high expression of CYP7A1 in the humanized livers leads to high production of bile acids.
The researchers then investigated whether
FGF19 regulation of
CYP7A1 and bile acid production control liver size in FRGN mice
They inserted the gene encoding human FGF19, including its regulatory sequences, into the FRGN mice to create
FRGN19+ mice. Livers of
FRGN19+ mice and their FRGN littermates were then fully repopulated with human hepatocytes.
As previously observed, livers were larger in FRGN mice with humanized livers (13% of body weight), compared with control FRGN mice, due to increased hepatocyte proliferation; FRGN mice with humanized livers also had much larger bile acid pools and aberrant bile acid signaling. However, livers from FRGN19+ were normalized, to 7.8% of body weight; their bile acid pool and signaling more closely resembled that of control mice.
The authors concluded that FGF19 intestine–liver signaling controls bile acid homeostasis and liver size.Please read the rest here:
https://journalsblog.gastro.org/what-controls-liver-size/I believe the take home message here is that the science is incomplete, but we're getting to the point of understanding how liver size is regulated in animals. In addition, regulation of organ size also depends on the organ. Obviously, the pathway that regulates liver is different than what regulates kidneys, so each one would need to be investigated individually. There's no simple black or white answer for your question, apart from what I generally wrote in my initial post.